Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy
Top Cited Papers
Open Access
- 1 January 2007
- journal article
- review article
- Published by Hindawi Limited in Experimental Diabetes Research
- Vol. 2007, 1-14
- https://doi.org/10.1155/2007/95103
Abstract
Diabetes causes metabolic and physiologic abnormalities in the retina, and these changes suggest a role for inflammation in the development of diabetic retinopathy. These changes include upregulation of iNOS, COX-2, ICAM-1, caspase 1, VEGF, and NF-B, increased production of nitric oxide, prostaglandin E2, IL-1, and cytokines, as well as increased permeability and leukostasis. Using selective pharmacologic inhibitors or genetically modified animals, an increasing number of therapeutic approaches have been identified that significantly inhibit development of at least the early stages of diabetic retinopathy, especially occlusion and degeneration of retinal capillaries. A common feature of a number of these therapies is that they inhibit production of inflammatory mediators. The concept that localized inflammatory processes play a role in the development of diabetic retinopathy is relatively new, but evidence that supports the hypothesis is accumulating rapidly. This new hypothesis offers new insight into the pathogenesis of diabetic retinopathy, and offers novel targets to inhibit the ocular disease.
Keywords
Funding Information
- Medical Research Service of the Department of Veteran Affairs (EY00300, DK57733)
This publication has 143 references indexed in Scilit:
- Revisiting safety of minocycline as neuroprotection in Huntington's diseaseMovement Disorders, 2006
- INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)Retina, 2006
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006
- Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema: A Prospective, Randomized StudyJournal of Ocular Pharmacology and Therapeutics, 2006
- Glucocorticoid Regulation of Endothelial Cell Tight Junction Gene Expression: Novel Treatments for Diabetic RetinopathyCurrent Eye Research, 2005
- The Role of Advanced Glycation End Products in Retinal Microvascular LeukostasisInvestigative Ophthalmology & Visual Science, 2003
- Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humansCurrent Eye Research, 2003
- Efficient Scavenging of Fatty Acid Oxidation Products by AminoguanidineChemical Research in Toxicology, 1997
- Leukocyte-Capillary Plugging and Network Resistance Are Increased in Skeletal Muscle of Rats with Streptozotocin-Induced HyperglycemiaInternational Journal of Microcirculation, 1994
- Discordant effects of the aldose resuctase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic ratsJournal of Diabetic Complications, 1991